Navigation Links
Protein Engineering Market worth $168 Billion by 2017

DALLAS, March 20, 2013 /PRNewswire/ --

The report "Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017", analyses the global protein engineering market by products, technology, applications, and geography with five-year revenue forecasts. It also identifies the factors driving and restraining the global protein engineering market with analysis of trends, opportunities, and threats.


  • 11 market data tables
  • 44 figures
  • 148 Slides and an in-depth Table of Content on "Protein Engineering Market"

Early buyers will receive 10% customization on this report.

The protein engineering market is divided into three segments based on its applications, namely, therapeutics, diagnostics, and research. The protein engineering market includes therapeutic proteins (monoclonal antibodies, insulin analogs, EPO, and other proteins), diagnostic proteins, and engineered proteins used in research applications. Monoclonal antibodies is the fastest growing segment of the protein engineering market; it is further segmented based on its application for cancer, auto immune diseases, inflammatory diseases, neovascular and haemostasis.

The global market for engineered protein products is estimated to be worth $168 billion by 2017, growing at a CAGR of 10.94% from 2012 to 2017. Proteins are used as therapeutics owing to their specificity and less immunogenic responses within the host system. Diversity in protein architecture and its properties offers scope for new and improved versions of therapeutic proteins with improved function and stability. The protein engineering market products is growing due to an increase in prevalence of cancer, autoimmune, inflammatory and infectious diseases. These diseases need a targeted therapeutic approach for treatment, which is achieved by therapeutic proteins. Monoclonal antibody is the fastest growing product segment in the market with more than 50% market share. There are more than 25 monoclonal antibodies approved for therapeutics; 10 of these are blockbuster drugs with more than $1 billion in annual revenue. Other products like insulin analogs, EPO, enzymes, and growth hormones are expected to grow at a medium pace.

U.S. and Europe have been major protein engineering market products; however, Asia is set to grow at a faster pace with India's growth in the field of biotechnology and Chinas interest in the research of monoclonal antibodies. Indonesia is the fourth-largest diabetic population nation, and South Koreas growing cancer incidence rate is expected to propel the market for protein therapeutics in the region.

Key players in the market include Genetech (U.S.), Amgen(U.S.), Roche (Switzerland), Eli Lilly (U.S.), Novartis (Switzerland), GSK (U.K.), BMS (U.S.), Johnson & Johnson(U.S.), Merck (U.S.), Pfizer (U.S.), Sanofi (France), Affymax (U.S.), Biogen Idec (U.S.), and Medimmune (U.S.).

Buy a copy of this report @

 About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defence.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Visit MarketsandMarkets Blog @
Connect with us on LinkedIn @
Visit our Google plus Profile @

SOURCE MarketsandMarkets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Tenfold boost in ability to pinpoint proteins in cancer cells
2. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
3. Penn researchers develop protein passport that help nanoparticles get past immune system
4. Dr. Wayne Hachey Joins Protein Sciences Leadership Team
5. transOMIC technologies Releases Tagged ORF Clones for Protein Expression
6. Waters Unveils Industrys First Integrated LC/MS Platform for Proteins, Peptides, and Glycans Analysis at WCBP 2013
7. CSL Behring enrolls first patient in global pediatric Phase III pivotal study of recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) to treat hemophilia B
8. Intrinsically disordered proteins: A conversation with Rohit Pappu
9. NIH media availability: Protein linked to increased risk of heart failure and death in older adults
10. Protein that helps tumor blood vessels mature could make cancer drugs more effective
11. Frost & Sullivan Recognizes MicroProtein Technologies for its Path-Breaking Production Technology for Recombinant Proteins in Bacteria
Post Your Comments:
(Date:11/24/2015)... AVIV, Israel , Nov. 24, 2015  Tikcro Technologies Ltd. (OTCQB: ... held on December 29, 2015 at 11:00 a.m. Israel ... Co., Electra Tower, 98 Yigal Allon Street, 36 th Floor, ... election of Eric Paneth and Izhak Tamir to ... and Rami Skaliter as external directors; , approval of an amendment ...
(Date:11/24/2015)... Urdorf, Switzerland (PRWEB) , ... November 24, 2015 ... ... the plant and the environment are paramount. Insertion points for in-line sensors can ... TOLEDO has developed the InTrac 781/784 series of retractable sensor housings , ...
(Date:11/24/2015)... Telbec/ - ProMetic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ... Laurin , President and Chief Executive Officer of ProMetic, will ... 27 th Annual Healthcare Conference to be held at ... st , at 8.50am (ET) and ProMetic,s management ... The presentation will be available live via a webcast accessible ...
(Date:11/24/2015)... , Nov. 24, 2015  PDL BioPharma, Inc. (PDL) (NASDAQ: ... , the company,s president and chief executive officer, will present ... next week in New York City . ... Tuesday, December 1, 2015 at 9:30 a.m. EST. ... to the website at least 15 minutes prior to the ...
Breaking Biology Technology:
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... Oct. 29, 2015  Rubicon Genomics, Inc., today ... distribution of its DNA library preparation products, including ... new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has been ... of NGS libraries for liquid biopsies--the analysis of ... prognostic applications in cancer and other conditions. Eurofins ...
(Date:10/27/2015)... 27, 2015 In the present market scenario, ... for various industry verticals such as banking, healthcare, defense, ... growing demand for secure & simplified access control and ... as hacking of bank accounts, misuse of users, , ... as PC,s, laptops, and smartphones are expected to provide ...
Breaking Biology News(10 mins):